Loading clinical trials...
Loading clinical trials...
Rituximab Plus Bendamustine as Front Line Treatment in Frail Elderly (>70 Years) Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma: a Phase II Multicenter Study of the Fondazione Italiana Linfomi (FIL)
Conditions
Interventions
Bendamustine+Rituximab
Locations
52
Italy
Ospedale Civile Ss. Antonio E Biagio Di Alessandria
Alessandria, Alessandria, Italy
Ente Eccl.Osp.Gen.Reg.'Miulli'
Acquaviva delle Fonti, Bari, Italy
Ospedale S. Nicola Pellegrino Di Trani
Trani, Barletta, Italy
Asp Di Bolzano - Comprensorio Sanitario Di Bolzano
Bolzano, Bolzano, Italy
Pres.Ospedal.Spedali Civili Brescia
Brescia, Brescia, Italy
Stabilimento "Perrino"
Brindisi, Brindisi, Italy
Start Date
November 1, 2011
Primary Completion Date
February 1, 2014
Completion Date
February 1, 2016
Last Updated
November 21, 2013
NCT05139017
NCT01804686
NCT05755087
NCT04739813
NCT06785818
NCT06043011
Lead Sponsor
Fondazione Italiana Linfomi - ETS
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions